Hope for haloperidol in delirium

The Lancet Respiratory Medicine

Volumn 1, Issue 8, 2013, Pages

  van den Boogaard, Mark ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; DOPAMINE RECEPTOR BLOCKING AGENT;

AGITATION; ARTIFICIAL VENTILATION; CRITICALLY ILL PATIENT; DELIRIUM; DRUG EFFICACY; HUMAN; INTENSIVE CARE UNIT; LETTER; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; TREATMENT OUTCOME; COMA; FEMALE; MALE;

COMA; DELIRIUM; DOPAMINE ANTAGONISTS; FEMALE; HALOPERIDOL; HUMANS; MALE;

EID: 84885031808     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70210-8     Document Type: Letter

References (5)

1. Page VJ, Ely EW, Gates S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial. Lancet Respir Med 2013, 1:515-523.
2. Wang W, Li HL, Wang DX, et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial. Crit Care Med 2012, 40:1-9.
3. van den Boogaard M, Schoonhoven L, Van Achterberg T, Van der Hoeven JG, Pickkers P Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Critical Care 2013, 17:R9.
4. Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med 2009, 180:1092-1097.
5. van den Boogaard M, Pickkers P, Slooter AJ, et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICu patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ 2012, 344:e420.